BiotechTube
Home/MAB Designs/Prof. John Wijdenes
PJ

Prof. John Wijdenes

Chief Scientific Officer, Co-founder

MAB Designs

Therapeutic Areas

Inflammatory DiseasesAutoimmune Diseases

MAB Designs Pipeline

DrugIndicationPhase
Anti-IL-6 AntibodyInflammatory/Autoimmune Diseases (via selective trans-signaling inhibition)Pre-clinical

Leadership Team at MAB Designs

AC
Andrew Clark
Managing Director, Co-founder
View full MAB Designs profile